CKS Pharma Labs Private Limited
About CKS Pharma Labs Private Limited
Data last updated:
CKS Pharma Labs Private Limited is a private limited company based in Krishna, Andhra Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 06 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2010PTC069851. Its GSTIN is 37AAECC4962C1ZS (Andhra Pradesh).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.37 Cr. It is led by directors including Bandaru Venkateswara Rao (Managing Director) and Baba Murali Dhar Ravavarapu.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Rs No.1 – 27 Vedadri Village, Krishna, Andhra Pradesh, India – 521175.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.4 Cr, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹71.75 Lakh (net margin -11.2%) and EBITDA of ₹20.43 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 13% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.83 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRs No.1 – 27 Vedadri Village, Krishna, Andhra Pradesh, India – 521175
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of CKS Pharma Labs Private Limited
The main business activity of CKS Pharma Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of CKS Pharma Labs Private Limited FY 2022 filings available
CKS Pharma Labs Private Limited reported revenue of ₹6.4 Cr (down 64% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of CKS Pharma Labs Private Limited
Revenue fell 64% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of CKS Pharma Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.43 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹71.75 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of CKS Pharma Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -11.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of CKS Pharma Labs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of CKS Pharma Labs Private Limited
CKS Pharma Labs Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivaya Medical Devices Private Limited | ₹6.42 Cr (FY 2025) | •••• | •••• | 106.0% | •••• | Balianta, Odisha, India |
| Clinicare (India) Private Limited | ₹6.41 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Aar Ess Remedies Private Limited | ₹6.41 Cr (FY 2025) | •••• | •••• | -44.0% | •••• | New Delhi, Delhi, India |
| Omc Chemicals and Allied Chromatography Private Limited | ₹6.41 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Nuorik Healthcare Private Limited | ₹6.41 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | New Delhi, Delhi, India |
| CKS Pharma Labs Private Limited this company | ₹6.4 Cr (FY 2022) | •••• | •••• | -64.0% | •••• | Krishna, Andhra Pradesh, India |
| Gateway Chemists Private Limited | ₹6.39 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Fortune Meditech (India) Private Limited | ₹6.38 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Delhi, India |
| Albatross Homes Private Limited | ₹6.38 Cr (FY 2025) | •••• | •••• | 206.0% | •••• | New Delhi, Delhi, India |
| V.M.Meditech Private Limited | ₹6.38 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Chennai, Tamil Nadu, India |
| Rohini Global Marketing Private Limited | ₹6.37 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below CKS Pharma Labs by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of CKS Pharma Labs Private Limited
CKS Pharma Labs Private Limited is audited by V NAGA RAJU & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V NAGA RAJU & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of CKS Pharma Labs Private Limited
CKS Pharma Labs has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Baba Murali Dhar Ravavarapu | Director | 10 May 2013 | 13 Years 5 Months | Current |
| Koduri Krishnaiah | Director | 10 May 2013 | 13 Years 5 Months | Current |
| Bandaru Venkateswara Rao Also directs: VB Multichem Private Limited | Managing Director | 06 Jan 2016 | 10 Years 9 Months | Current |
| Kishore Sudulagunta | Director | 06 Aug 2010 | 16 Years 2 Months | Current |
Ownership and Shareholding of CKS Pharma Labs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of CKS Pharma Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2013 | Others | ₹7.83 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of CKS Pharma Labs Private Limited
CKS Pharma Labs Private Limited has 3 court cases on record: 2 filed by CKS Pharma Labs, 1 where it is another party. 1 case is pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Deputy Commissioner (CT) | Pending |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Deputy Assistant Commissioner (St)-I | Disposed |
| High Court for State of Telangana | Writ petition | Company is another party | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at CKS Pharma Labs Private Limited
CKS Pharma Labs Private Limited has a workforce of 8 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on CKS Pharma Labs Private Limited
CKS Pharma Labs Private Limited has 13 board changes on record since 2010: 4 appointments and 9 cessations. The latest: Ganga Bhavani Bandaru ceased to be Director on 06 Mar 2023.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for CKS Pharma Labs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by CKS Pharma Labs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of CKS Pharma Labs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of CKS Pharma Labs Private Limited
CKS Pharma Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECC4962C1ZS | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of CKS Pharma Labs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CKS Pharma Labs Private Limited
CKS Pharma Labs is an active private limited company based in Krishna, Andhra Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 06 August 2010 (16+ years old) and is registered under CIN U24100AP2010PTC069851.
CKS Pharma Labs reported revenue of ₹6.4 Cr for FY 2022 (down 64% YoY).
CKS Pharma Labs has 4 current directors:
- Bandaru Venkateswara Rao - Managing Director
- Baba Murali Dhar Ravavarapu - Director
- Koduri Krishnaiah - Director
- Kishore Sudulagunta - Director
CKS Pharma Labs reported a net loss of ₹71.75 Lakh (net margin -11.2%) and EBITDA of ₹20.43 Lakh (EBITDA margin 3.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of CKS Pharma Labs is -15% over three years and 13% over five years. In the latest year (FY 2022) revenue fell 64%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of CKS Pharma Labs is 37AAECC4962C1ZS, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of CKS Pharma Labs is U24100AP2010PTC069851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CKS Pharma Labs has 3 court cases on record: 2 filed by the company. 1 is pending.
CKS Pharma Labs was incorporated on 06 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of CKS Pharma Labs by revenue are Shivaya Medical Devices Private Limited, Clinicare (India) Private Limited, Aar Ess Remedies Private Limited, Omc Chemicals and Allied Chromatography Private Limited, Nuorik Healthcare Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).
Ganga Bhavani Bandaru ceased to be Director on 06 Mar 2023. Kasina Shekar Raja ceased to be Director on 22 Apr 2022. Bandi Naga Mohan Reddy ceased to be Additional Director on 29 Sep 2018. CKS Pharma Labs has 13 board changes on record in total.